NVCT
Nuvectis Pharma, Inc.
-0.42 (-1.92%)21.45USD26.6K成交股數699M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 4.7M | 4.1M | 5.1M | 5.8M | 3.6M | 3.7M | 2.8M | 2.9M | 2.7M | 4.3M | 4.5M | 4.3M |
| 銷售管理費用 | 2.5M | 2.2M | 2.5M | 2.0M | 3.0M | 1.9M | 1.5M | 1.7M | 1.7M | 2.6M | 1.7M | 1.5M |
| 營業利益 | −7.2M+9% | −6.3M+12% | −7.6M+75% | −7.8M+68% | −6.6M+50% | −5.6M-19% | −4.4M-29% | −4.6M-20% | −4.4M | −6.9M | −6.2M | −5.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −7.0M+11% | −6.1M+13% | −7.3M+76% | −7.5M+69% | −6.3M+52% | −5.3M-19% | −4.2M-29% | −4.4M-22% | −4.2M | −6.6M | −5.9M | −5.7M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.300% | -0.26-4% | -0.31+29% | -0.44+69% | -0.30+20% | -0.27-34% | -0.24-35% | -0.26-32% | -0.25 | -0.41 | -0.37 | -0.38 |
| 稀釋股數 | 23.5M | 23.4M | 21.8M | 22.7M | 21.4M | 19.9M | 17.2M | 16.9M | 16.6M | 15.6M | 16.1M | 15.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 22.2M | 25.1M | 31.6M | 35.4M | 26.8M | 29.9M | 17.2M | 18.1M | 19.5M | 19.1M | 22.1M | 24.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 22.4M | 25.4M | 31.7M | 35.6M | 27.0M | 30.1M | 17.3M | 18.3M | 19.7M | 19.2M | 22.3M | 24.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 13.3M | 11.2M | 13.3M | 11.6M | 10.1M | 9.2M | 6.3M | 5.8M | 5.7M | 7.0M | 5.6M | 4.6M |
| 股東權益 | 9.1M | 14.2M | 18.4M | 24.0M | 16.9M | 21.0M | 11.0M | 12.5M | 14.0M | 12.2M | 16.7M | 20.3M |
| 負債比 | 59.4% | 44.0% | 41.9% | 32.5% | 37.5% | 30.5% | 36.5% | 31.5% | 28.9% | 36.4% | 25.0% | 18.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −6.5M+56% | – | – | – | −4.2M | – | – | −4.4M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −26.4M | –% | -1.32 | – |
| FY2024 | – | – | −19.0M | –% | -1.11 | – |
| FY2023 | – | – | −22.3M | –% | -1.43 | – |
| FY2022 | – | – | −19.1M | –% | -1.51 | – |
| FY2021 | – | – | −12.9M | –% | -3.02 | – |